{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:26:53Z","timestamp":1770283613389,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00125-015-3685-6","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T07:20:06Z","timestamp":1436426406000},"page":"2344-2351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Influence of endogenous NEFA on beta cell function in humans"],"prefix":"10.1007","volume":"58","author":[{"given":"Eleni","family":"Rebelos","sequence":"first","affiliation":[]},{"given":"Marta","family":"Seghieri","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[]},{"given":"Beverly","family":"Balkau","sequence":"additional","affiliation":[]},{"given":"Alain","family":"Golay","sequence":"additional","affiliation":[]},{"given":"Pier Marco","family":"Piatti","sequence":"additional","affiliation":[]},{"given":"Nebojsa M.","family":"Lalic","sequence":"additional","affiliation":[]},{"given":"Markku","family":"Laakso","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"3685_CR1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1079\/PNS19970076","volume":"56","author":"E Ferrannini","year":"1997","unstructured":"Ferrannini E, Camastra S, Coppack SW, Fliser D, Golay A, Mitrakou A (1997) Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). Proc Nutr Soc 56:753\u2013761","journal-title":"Proc Nutr Soc"},{"key":"3685_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.plipres.2009.05.001","volume":"48","author":"M Lafontan","year":"2009","unstructured":"Lafontan M, Langin D (2009) Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48:275\u2013797","journal-title":"Prog Lipid Res"},{"key":"3685_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785\u2013789","journal-title":"Lancet"},{"key":"3685_CR4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","volume":"375","author":"VT Samuel","year":"2010","unstructured":"Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267\u20132277","journal-title":"Lancet"},{"key":"3685_CR5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2337\/diab.44.8.863","volume":"44","author":"RH Unger","year":"1995","unstructured":"Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863\u2013870","journal-title":"Diabetes"},{"key":"3685_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2337\/diabetes.50.2.315","volume":"50","author":"I Briaud","year":"2001","unstructured":"Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V (2001) Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50:315\u2013321","journal-title":"Diabetes"},{"key":"3685_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","volume":"51","author":"JD McGarry","year":"2002","unstructured":"McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7\u201318","journal-title":"Diabetes"},{"key":"3685_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2337\/diab.43.5.703","volume":"43","author":"C Warnotte","year":"1994","unstructured":"Warnotte C, Gilon P, Nenquin M, Henquin JC (1994) Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes 43:703\u2013711","journal-title":"Diabetes"},{"key":"3685_CR9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI117042","volume":"93","author":"YP Zhou","year":"1994","unstructured":"Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870\u2013876","journal-title":"J Clin Invest"},{"key":"3685_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/endo.133.1.8319569","volume":"133","author":"ML Elks","year":"1993","unstructured":"Elks ML (1993) Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 133:208\u2013214","journal-title":"Endocrinology"},{"key":"3685_CR11","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1172\/JCI118727","volume":"97","author":"DT Stein","year":"1996","unstructured":"Stein DT, Esser V, Stevenson BE et al (1996) Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728\u20132735","journal-title":"J Clin Invest"},{"key":"3685_CR12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1210\/endo-127-4-1580","volume":"127","author":"Y Sako","year":"1990","unstructured":"Sako Y, Grill VE (1990) A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580\u20131589","journal-title":"Endocrinology"},{"key":"3685_CR13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2337\/diabetes.48.3.524","volume":"48","author":"TM Mason","year":"1999","unstructured":"Mason TM, Goh T, Tchipashvili V et al (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524\u2013530","journal-title":"Diabetes"},{"key":"3685_CR14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/diab.44.10.1239","volume":"44","author":"G Boden","year":"1995","unstructured":"Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239\u20131242","journal-title":"Diabetes"},{"key":"3685_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2337\/diabetes.48.3.577","volume":"48","author":"G Boden","year":"1999","unstructured":"Boden G, Chen X (1999) Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes 48:577\u2013583","journal-title":"Diabetes"},{"key":"3685_CR16","first-page":"E1055","volume":"276","author":"A Carpentier","year":"1999","unstructured":"Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055\u2013E1066","journal-title":"Am J Physiol"},{"key":"3685_CR17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diabetes.49.3.399","volume":"49","author":"A Carpentier","year":"2000","unstructured":"Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF (2000) Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399\u2013408","journal-title":"Diabetes"},{"key":"3685_CR18","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","volume":"52","author":"S Kashyap","year":"2003","unstructured":"Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461\u20132474","journal-title":"Diabetes"},{"key":"3685_CR19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/BF00422371","volume":"38","author":"G Paolisso","year":"1995","unstructured":"Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213\u20131217","journal-title":"Diabetologia"},{"key":"3685_CR20","doi-asserted-by":"crossref","first-page":"E1156","DOI":"10.1152\/ajpendo.00427.2002","volume":"284","author":"N Stefan","year":"2003","unstructured":"Stefan N, Stumvoll M, Bogardus C, Tataranni PA (2003) Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. Am J Physiol Endocrinol Metab 284:E1156\u2013E1161","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3685_CR21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","volume":"47","author":"SA Hills","year":"2004","unstructured":"Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566\u2013570","journal-title":"Diabetologia"},{"key":"3685_CR22","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1210\/jc.2007-0334","volume":"92","author":"E Ferrannini","year":"2007","unstructured":"Ferrannini E, Balkau B, Coppack SW et al (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92:2885\u20132892","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"3685_CR23","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","volume":"51","author":"A Mari","year":"2002","unstructured":"Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221\u2013S226","journal-title":"Diabetes"},{"key":"3685_CR24","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1152\/ajpendo.00093.2002","volume":"283","author":"A Mari","year":"2002","unstructured":"Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159\u2013E1166","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 4","key":"3685_CR25","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1463-1326.2008.00946.x","volume":"10","author":"A Mari","year":"2008","unstructured":"Mari A, Ferrannini E (2008) Beta-cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab 10(Suppl 4):S77\u2013S87","journal-title":"Diabetes Obes Metab"},{"key":"3685_CR26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","volume":"41","author":"E Cauter Van","year":"1992","unstructured":"Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368\u2013377","journal-title":"Diabetes"},{"key":"3685_CR27","doi-asserted-by":"crossref","first-page":"e18134","DOI":"10.1371\/journal.pone.0018134","volume":"6","author":"D Stefanovski","year":"2011","unstructured":"Stefanovski D, Richey JM, Woolcott O et al (2011) Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA. PLoS One 6:e18134","journal-title":"PLoS One"},{"key":"3685_CR28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jcem-72-1-96","volume":"72","author":"LC Groop","year":"1991","unstructured":"Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA (1991) The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96\u2013107","journal-title":"J Clin Endocrinol Metab"},{"key":"3685_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI114142","volume":"84","author":"LC Groop","year":"1989","unstructured":"Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205\u2013213","journal-title":"J Clin Invest"},{"key":"3685_CR30","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2337\/diabetes.48.9.1836","volume":"48","author":"AT Santomauro","year":"1999","unstructured":"Santomauro AT, Boden G, Silva ME et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836\u20131841","journal-title":"Diabetes"},{"key":"3685_CR31","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/db11-0425","volume":"60","author":"F Karpe","year":"2011","unstructured":"Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60:2441\u20132449","journal-title":"Diabetes"},{"key":"3685_CR32","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2337\/diabetes.47.10.1613","volume":"7","author":"RL Dobbins","year":"1998","unstructured":"Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT (1998) Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 7:1613\u20131618","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"3685_CR33","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diabetes.53.suppl_3.S79","volume":"53","author":"E Santini","year":"2004","unstructured":"Santini E, Fallahi P, Ferrari SM, Masoni A, Antonelli A, Ferrannini E (2004) Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cells. Diabetes 53(Suppl 3):S79\u2013S83","journal-title":"Diabetes"},{"key":"3685_CR34","doi-asserted-by":"crossref","first-page":"e74927","DOI":"10.1371\/journal.pone.0074927","volume":"8","author":"C Hellmuth","year":"2013","unstructured":"Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Bluher M, Koletzko B (2013) Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS One 8:e74927","journal-title":"PLoS One"},{"key":"3685_CR35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1464-5491.1999.00184.x","volume":"16","author":"CD Byrne","year":"1999","unstructured":"Byrne CD, Maison P, Halsall D, Martensz N, Hales CN, Wareham NJ (1999) Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome. Diabet Med 16:1007\u20131015","journal-title":"Diabet Med"},{"key":"3685_CR36","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1210\/jc.2012-1428","volume":"97","author":"B Salgin","year":"2012","unstructured":"Salgin B, Ong KK, Thankamony A, Emmett P, Wareham NJ, Dunger DB (2012) Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 97:3302\u20133309","journal-title":"J Clin Endocrinol Metab"},{"key":"3685_CR37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2008.10.043","volume":"135","author":"MP Gillum","year":"2008","unstructured":"Gillum MP, Zhang D, Zhang XM et al (2008) N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. Cell 135:813\u2013824","journal-title":"Cell"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3685-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-015-3685-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3685-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T03:22:59Z","timestamp":1566962579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-015-3685-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1007\/s00125-015-3685-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]}}}